Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment.

Front Immunol · 2023 · PMC9893006 · PMID 36742315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The results demonstrated that the expression of the activation marker CD38 on the CD4 + T subset was significantly decreased in TKI-F patients compared with HIs (19.6% vs 10.5%, P = 0.0020) ( Figures 1D and F ), while the level of CD69 and HLA-DR also showed a decreasing trend on the CD4 + and CD8 + T subset respectively ( Figure 1F ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.